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a well-ordered polypeptide loop on the surface of the tetramer. Residues
150–153 of the extension are bound to the ligand-binding site, possibly
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compared with that of biotin and peptidic ligands. The observed structure
helps to rationalize the observations that full-length mature streptavidin
binds biotinylated macromolecules with reduced affinity.
Keywords: full-length streptavidin; crystallography; self-binding; protein/
ligand interactions*Corresponding authorIntroduction
Streptavidin binds biotin with high affinity
(Kdw10
K13 M).1 This makes it of considerable use
in biotechnical applications involving labeling and
transport of biochemical reagents. The tight binding
between streptavidin and biotin is also the subject
of biophysical, structural and computational inves-
tigations probing the nature of the protein–ligand
interactions.2–5
Streptavidin, after expression in Streptomyces
avidinii as a polypeptide of 159 residues, is rapidly
cleaved by proteases to yield several truncated
versions of the protein.6 The most stable and well-
studied form of the protein contains residues
13–139 and is called core-streptavidin. The crystal
structure of core streptavidin,7,8 showed that the
protein is a tetramer with D2 symmetry. Each
subunit contains a b-barrel structure with a biotin-
binding site located at one end of the barrel.
The biotin-binding site is made up of several
hydrogen bonding amino acid side-chains (N23,
S27, Y43, S45, and D128) as well as several
tryptophan residues (W79, W92, W108, and W120
(from a neighboring subunit)). There are extensivegged streptavidin;
ing author:subunit–subunit interactions in the tetramer,
and each biotin site contains residues from two
subunits. In addition, a flexible binding loop (resi-
dues 45–52) undergoes a conformational change
upon ligand binding and closes over the binding
site, nearly burying it from the aqueous environment.
Streptavidin/ligand interactions have been
probed both by mutating the protein5,9,10 and by
varying the structure of the ligand.11–14 These
studies have been driven by theoretical as well as
biotechnical considerations, and a number of crystal
structures of streptavidin and its ligands are
available in the Protein Data Bank.
Streptavidin exists in a number of forms in
S. avidinii.6 These appear to be cleavage products
of the 159 residue form termed mature, full-length
streptavidin. Several reports suggest that strept-
avidins truncated at the C terminus display enhanced
binding affinity for large biotinylated macro-
molecules.6,15 To date, no crystallographic structural
information for the full-length streptavidin has been
available to explain this reduced affinity.
In recent years, one of us has reported on the use
of mature streptavidin as a host protein for
biotinylated organometallic catalyst precursors.
Such artificial metalloenzymes show promising
properties as hybrid catalysts for enantioselective
hydrogenation and transfer hydrogenation
reactions.16–18 With the aim of solving the X-ray
structure of such artificial metalloenzymes, we have
solved the structure of unliganded, full-length
Table 1. Diffraction data statistics
Resolution
shells (A˚)
Number
reflections hIi Error Redundancy % Complete Norm. c2 Rmerge
50.0–3.30 4556 285,687.5 13,809.4 4.2 98.6 0.947 0.054
3.30–2.62 4552 110,429.5 5318.9 4.2 99.7 1.086 0.060
2.62–2.29 4544 44,891.6 2462.8 4.1 99.8 0.987 0.062
2.29–2.08 4532 31,710.9 1845.6 4.0 99.7 1.169 0.068
2.08–1.93 4515 19,061.8 1376.5 4.0 99.7 1.155 0.085
1.93–1.81 4504 9384.7 873.5 4.0 100.0 1.156 0.119
1.81–1.72 3938 4754.1 579.7 3.5 86.5 1.321 0.160
1.72–1.65 2528 2568.2 452.1 2.9 55.9 1.430 0.216
1.65–1.68 1394 1461.1 363.0 2.4 30.7 1.514 0.259
1.58–1.53 318 1039.5 355.2 1.7 7.1 1.483 0.270
Overall 35,381 65,229.5 3416.4 3.8 77.9 1.131 0.061
2streptavidin at 1.7 A˚ resolution. The protein
construct, designated T7-SA, is 159 residues long
with the first 13 residues of streptavidin being
replaced by a T7 epitope tag†. The C-terminal
extension beyond residue 139, the normal core-
streptavidin terminus, folds back on the protein and
occupies the biotin-binding site. Here we describe
the structure of this self-binding streptavidin.Table 2. Refinement statistics
Resolution range (A˚) (but reflections to
1.53 A˚ included in the refinement)
10.0–1.7
Number of unique reflections 35,214
Number of reflections in working set 31,693
Number of reflections in working set with
jFojO4s(jFoj)
29,622
Number of reflections in test set 3521
Number of reflections in test set with
jFojO4s(jFoj)
3296
Number of parameters 9763
Number of restraints 6886
Rwork (all reflections) 0.175
Rwork (jFojO4s(jFoj)) 0.171
Rfree (all reflections) 0.244
Rfree (jFojO4s(jFoj)) 0.236
Rfinal (all reflections) 0.179
Rfinal (jFojO4s(jFoj)) 0.176
Goodness of fit 4.157
Number of protein atoms 2151
Number of solvent atoms 279
Number of heteroatoms 15
Mean B value (isotropic) (A˚2) 44.2
Main-chain atoms 42.7
Side-chain atoms 44.2Results and Discussion
Data set and refinement statistics for the T7-SA
crystal structure are presented in Tables 1 and 2. The
data set used in refinement has an effective
resolution of about 1.7 A˚. While reflections to
1.53 A˚ resolution were used in the refinement, the
outer shells of data are not complete, presumably
due to the shape of the detector. The effect of this on
the refinement and the resulting electron density
maps is not known, but it seems unlikely to affect
the overall structure in significant ways.
Two T7-SA subunits are found in the asymmetric
unit of the unit cell reported here, but the crystal
actually contains streptavidin tetramers possessing
222 (D2) symmetry. They have arranged themselves
in the crystal with one of the tetrameric 2-fold rotation
axes coinciding with a crystallographic 2-fold axis in
the C2 space group. One of the non-crystallographic
2-fold axes in the tetramer is parallel to the a axis of the
unit cell. This, coupled with the C-centering operation
of the space group, results in layers of tetramers in the
a–b plane of the unit cell, with their third 2-fold
rotation axis (again non-crystallographic) perpen-
dicular to the layers. Adjacent layers are packed such
that the 2-fold rotation axes for one layer do not align
with those of the neighboring layer. Thus, these
2-folds must be non-crystallographic, and the space
group must be the monoclinic C2.
In T7-SA, the 13 N-terminal residues of full-
length streptavidin have been replaced by the
T7-tag known to solubilize recombinant proteins
(see Figure 1). In this crystal form, no electron density
is observed for the T7-tag. Core-streptavidin, the most
common form of the protein used in research and† http://www.merckbiosciences.co.uk/docs/docs/
PROT/TB055.pdftechnical applications, is comprised of residues
13–139, and is 20 amino acid residues shorter than
the full-length molecule at the C terminus.6 Electron
density is seen in the T7-SA crystal for residues 12
and 13 in one subunit, but not in the second. The
density for the N-terminal residues is not strong,
indicating the presence of static or dynamic
disorder in this part of the structure. T7-SA contains
the C-terminal extension and much of it is observed
in each of the two subunits in the asymmetric unit.
The structure of the streptavidin tetramer is
shown in Figure 2. The overall folding topology of
one of the unique T7-SA protomers in this crystal
structure is shown in blue in Figure 2. The
fundamental b-barrel fold found in other streptavidin
monomers in other crystal structures is found in T7-
SA as well. When compared to core-streptavidin,
one additional residue is seen at the N terminus
while 20 additional residues are seen at the C
terminus (17 in the second molecule in the
asymmetric unit). The C-terminal extension
stretches away from the b-barrel, forms a sectionSolvent and heteroatoms 52.7
r.m.s. deviations from ideal bond lengths (A˚) 0.010
r.m.s. deviations from ideal bond angles (A˚) 0.028
Figure 1. The amino acid sequence of T7 tagged mature
streptavidin. The T7 tag is used to increase the solubility
of recombinant proteins and replaces the 13 N-terminal
residues of full-length streptavidin in this construct. The
T7 tag is highlighted in magenta. The sequence of core-
streptavin (residues 13–139) is highlighted in yellow.
3of a-helix, and then folds against the b-barrel with
several residues located within the biotin-binding
site.
The C-terminal extension does not alter the
fundamental subunit interactions leading to the
streptavidin tetramer (see Figure 2). The additional
residues are located away from neighboring sub-
units and do not interact with any of them,
including subunits within the tetramer and sub-
units in adjacent tetramers in the crystal.
The major structural element of the C-terminal
extension is a 12 residue long a-helix. The tracing of
the polypeptide as shown in Figure 2 suggests that
the helix is loosely connected with the rest of the
protein structure. Figure 3 shows that the region
between the helix and the b-barrel is filled with
side-chains from several residues. These are largely
hydrophobic residues, consistent with this region
being part of a typical globular protein.
In fact, the additional residues for full-length
streptavidin are simply appended to the fundamentalbiotin-binding pocket. The additional residues at the C ter
formation of the streptavidin tetramer.protein fold of core-streptavidin. Figure 4 shows the
superposition of a subunit of wild-type core-
streptavidin (in complex with biotin) (PDB ident
1MK5) on a T7-SA subunit. The major difference in
the polypeptide folds for the two molecules is in the
flexible binding loop near residues 45–52. In the
wild-type biotin complex, this loop folds over
the bound ligand. In the T7-SA structure, the loop
remains flexible in the open position (as found in
wild-type core-streptavidin), flexible enough that
electron density is not seen for several of the
residues in the loop.
A smaller conformational difference between
T7-SA and core-streptavidin is seen near residues
24–26 (see Figure 5). These residues in T7-SA are
shifted as much as 2.5 A˚ from their positions in
core-streptavidin, possibly to maximize hydro-
phobic contacts with the C-terminal helix and
neighboring residues. The movement appears to
be a semi-rigid rotation of that loop away from the
ligand-binding site.
The novel characteristic of this crystal structure is
the presence of residues 150–153 at the C-terminal
end of the polypeptide in the biotin-binding site.
These residues occupy a larger volume than does
biotin, so the flexible loop (residues 45–52) is not
able to fold over the binding site as it does in the
biotin complex with wild-type core-streptavidin.
Among the many streptavidin-ligand complexes
in the Protein Data Bank several contain small
exogenous peptides in the biotin site. Visual
inspection of 30 of these complexes confirms that
they bind to the biotin site in streptavidin in similar
ways. PDB entry 1VWL13 is typical of this class of
complexes. Figure 6 shows the superposition of
T7-SA with the wild-type biotin complex and the
1VWL peptide complex. The polypeptide traces for
the C-terminal residues of T7-SA and the HPQ
peptide from 1VWL are quite different.
The interactions between the ligands (C-terminal
residues, biotin or HPQ peptide) and the binding
site vary from ligand to ligand, except for one
hydrogen bond. The overlap of the three ligands is
shown, as well as two hydrogen bonding inter-
actions of particular interest, in Figure 7. In all three
complexes, there is a hydrogen bond between theFigure 2. Stereo view of the T7-
SA tetramer showing the quatern-
ary structure as well as the overall
folding topology and b-barrel fold
of the T7-SA subunit. In the
blue subunit, the residues corre-
sponding to core-streptavidin are
shown in light blue while the
additional residues at the N and C
terminus are in dark blue. At the C
terminus, the polypeptide forms an
a-helical segment before folding to
place several residues in the
minus do not alter the subunit interactions involved in
Figure 3. Stereo view of the C-terminal extension in the T7-SA protomer (blue backbone tracing). The space between
the helix and the b-barrel is filled with amino acid side-chains with non-hydrogen atoms shown as van der Waals
spheres.
4ligand and OG1 of Thr90. In the case of T7-SA, the
hydrogen bond acceptor is the carbonyl oxygen of
Gly151. For the biotin complex, the acceptor is the
sulfur atom, and for 1VWL, the acceptor is OE1 of
Gln5. The other hydrogen bond shown in Figure 7
involves the OG of Ser88. It interacts with the
valeric acid carboxylate in biotin and NE2 of His3 in
the peptide complex. In T7-SA, a proline occupiesFigure 4. Stereo view of a subunit of wild-type core-strepta
(blue coil). Biotin (bound in core-streptavidin) is shown in bal
biotin complex is shown in violet. The missing residues in th
transparent coil. The major differences between the wild-ty
residues at the C terminus, involve the conformation of the fle
of residues 24–26 near the a helix.the space occupied by the carboxylate in biotin, and
no hydrogen bond is formed with Ser88.
Further analysis of the interactions in T7-SA
between the C-terminal residues and the rest of the
subunit shows that very few hydrogen bonds are
involved. Table 3 lists the possible hydrogen bonds
in this part of the subunit structure. The bulk of the
hydrogen bond acceptors and donors in thevidin (PDB ident 1MK5) (pink coil) superposed on T7-SA
l-and-stick representation. The flexible binding loop in the
is loop in the open conformation in T7-SA are shown as
pe and T7-SA structures, in addition to the additional
xible binding loop (residues 45–52) and the conformation
Figure 5. Stereo view showing
the differences in the loop contain-
ing residues 24–26 in wild-type
core-streptavidin (pink) and T7-
SA (blue). These residues shift in
T7-SA in response to the additional
residues at the C-terminal end of
the polypeptide. The residues
appear to shift as a rigid unit.
Figure 6. Stereo view of the superposition of the polypeptide tracings of the subunits of T7-SA (blue coil), the biotin
complex of wild-type core-streptavidin (pink) and the peptide complex (PDB ident 1VWL13) (light green). The peptide
from the complex is shown as green coil. The flexible loop in the wild-type core-streptavidin–biotin complex is in
transparent violet while the missing residues in T7-SA are in transparent blue. The protein backbone for the C-terminal
residues of T7-SA does not align with the peptide ligand from 1VWL.
5C-terminal extension (residues 150–159) interact
with other atoms within the extension, not with
atoms in the core structure. This might allow this
part of the structure to be more flexible and might
contribute to its susceptibility to protease cleavage.6
The flexible binding loop (residues 45–52) is
unable to close over the portions of the C-terminalFigure 7. Stereo view of the ligands in the superposed comp
as are the biotin from the wild-type complex (pink bonds)
bonds). All three ligands make a hydrogen bond with OG1 oresidues that are located in the biotin-binding site in
T7-SA. Steric clashes with the residues in the
binding site, as well as adjacent residues, keep
the binding loop in the open, flexible position. The
electron density for several of the residues in this
loop in T7-SA was weak or missing, indicating that
portions of the loop are flexible in the crystals.lexes. Residues 151–153 of T7-SA are shown (blue bonds)
and the binding residues of the peptide complex (green
f Thr90.
Figure 8. Stereo view showing the
overlap of the flexible binding loop
in the wild-type core-streptavidin–
biotin complex (pink bonds) with
residues near the C terminus of
T7-SA (blue bonds). Residues
154–156 in T7-SA, while not actually
bound in the biotin-binding site, take
on the same conformation and
nearly the same location as the closed
loop in the wild-type–biotin
complex.
Table 3. Hydrogen bonds between residues 144–159 of
T7-SA and residues 12–143
Interatomic distance (A˚)
Chain A Chain B
Val148 N–Glu117a O 3.31 b
Asn149 O–Trp108 NE1 2.96 3.17
Gly151 O–Thr90 OG1 2.70 2.75
Asp155 O–Arg84 NH1 2.92 c
Asp155 O–Arg84 NE 3.17 c
Ala156 O–Tyr54 OH 2.70 c
Gln158 N–Ser52 OG 2.78 d
Gln158 OE1–Arg84 NH2 3.11 a
a Residue in the other polypeptide chain in the asymmetric
unit.
b Residue 117 in chain B modeled as Ala due to lack of electron
density.
c Side-chain in chain B in a conformation unable to form the
hydrogen bond.
d Residue 158 not modeled in chain B.
6The loop residues that have been located in T7-SA
take on the conformation of residues in other
streptavidin structures with open loop structures.
While the loop is open in this structure, three
residues (Leu154-Asp155-Ala156) just beyond the
three residues that mimic the binding of biotin, take
on conformations similar to those of the residues in
the closed form of the binding loop. Figure 8 shows
the overlap of these residues and the closed loop in
the biotin complex of wild-type core-streptavidin
(PDB ident 1MK5). The three residues (154–156)
overlap significantly, both in terms of structure and
sequence, with Gly48-Asn49-Ala50 (in the binding
loop). Residues 154–156 are translated from the
position of the closed loop by 1–2 A˚.
No part of the C terminus of T7-SA occupies the
pocket where the ureido oxygen of biotin binds in
the wild-type core-streptavidin complex. Instead,
the pocket is enlarged in T7-SA and is filled by two
water molecules (see Figure 9). The water molecules
make hydrogen bonds with several of the residues
that interact with the ureido oxygen atom andFigure 9. Stereo view of two water molecules in T7-SA occ
biotin in its complex with wild-type core-streptavidin (trans
molecules are shown as yellow broken lines. The binding po
molecules.nitrogen atoms of biotin, i.e. Ser27, Tyr43, and
Asp128. In addition, the water molecules are
hydrogen bonded to Gly151, Asn152, and Trp92.
In accommodating the additional volume associ-
ated with two water molecules, the binding pocket
has expanded. A major component of this expan-
sion is associated with the movement of residues
24–26 as shown in Figure 5.
The structure of T7-SA shows an interesting,
unexpected binding interaction between the
C-terminal residues of the full-length protein and
its biotin-binding site. Whether this binding mode
affects the binding of other ligands is not known.
Other investigators have shown that full-length
streptavidin can bind biotin,6,19 but quantitative
information concerning that interaction is not
readily available. The affinity of the C-terminal
residues for the biotin site is probably far weaker
than that of biotin since biotin makes use of the
ureido functional group in its interaction with
the protein while the C-terminal residues fail to
make use of analogous protein–ligand interactions.
It seems unlikely that the C-terminal residues
would compete effectively with biotin for the
binding site, but it is possible that more weakly
bound ligands might display significant binding
differences for core and full-length streptavidins.
As stated in the Introduction, full-length strep-
tavidin shows reduced binding of biotinylated
macromolecules6,15 compared with the binding
characteristics of core-streptavidin. The structure
of T7-SA shows that the additional residues at the
C-terminal end of the polypeptide produce an
a-helical segment and an extended peptide that
binds directly to the ligand-binding site. Since full-
length mature streptavidin can bind biotin, residues
150–159 must be flexible enough to allow them to
move from the binding site and permit binding.
The helical structure does not appear to be blocking
access to the binding site for small ligands, but, as
pointed out by Bayer et al.,15 it might be sufficient to
keep larger molecules from getting close enough toupying the binding pocket for the ureido oxygen atom of
parent atoms and bonds). Hydrogen bonds to the water
cket is enlarged in T7-SA to accommodate the two water
7bind their biotin labels in the normal ligand-binding
site.Materials and MethodsProtein characterization
Building upon Cantor’s mature streptavidin gene20 and
cloned by Santambroggio21 into the pET11b plasmid, we
redesigned the gene to incorporate a set of eight unique
restriction sites to allow casette mutagenesis. Experimen-
tal details, including high level expression, isolation,
purification and characterization of mature, full-length
streptavidin have been published elsewhere.22 Active site
quantification was achieved using biotin-4-fluorescein
using Gruber’s protocol.23Crystallization
T7-SA was crystallized using hanging-drop vapor-
diffusion techniques. Crystals were obtained by mixing
samples of the protein (26 mg/ml) with a 26% saturated
ammonium sulfate solution, 0.1 M sodium acetate
(pH 4.5), and allowing the drops to equilibrate with
a reservoir containing the same ammonium sulfate/
sodium acetate solution. The crystals were transferred to
40% saturated ammonium sulfate, 0.1 M sodium acetate
(pH 4.5), and 30% (v/v) glycerol in two steps before
freezing at 100 K in a nitrogen stream for diffraction data
collection.Data collection
Diffraction data for T7-SA were collected using an
in-lab R-Axis IVCC area detector (CuKa radiation). The
space group for the structure is C2, with a streptavidin
tetramer sitting on a crystallographic 2-fold axis. Two
streptavidin subunits are located in the asymmetric unit.
The unit cell dimensions are aZ81.70 A˚, bZ82.39, cZ
46.71, bZ103.488. The diffraction data were processed
with DENZO and merged and scaled with SCALE-
PACK.24 Data set statistics are shown in Table 1. The
mosaic spread for the crystal was 0.6468.Structure solution and refinement
The crystal structure of T7-SA was obtained using the
molecular replacement program, AMoRe,25 with a probe
structure consisting of a wild-type core-streptavidin
monomer. Two subunits were found in the asymmetric
unit. The structure was then refined using the SHELXL-97
program.26 Rfree
27 was calculated using 10% of the data
in the test set. The test set reflections were added to
the working set for the final refinement cycles and
electron density maps. Distance, planarity, chiral volume,
and anti-bumping restraints were applied. Target values
for the bond length and bond angle restraints were those
assembled by Engh & Huber.28 Similarity restraints were
applied to the atomic isotropic temperature factors.
A bulk solvent model was also applied.29
SHELXPRO was used for manipulating coordinates
and calculating Fourier coefficients for sigma A weighted
jFojKjFcj and 2jFojKjFcj electron density maps.30 Xtal-
View31 was used for graphical evaluation of the model
and electron density maps. The final model was validatedusing PROCHECK.32 Figures 2–9 were drawn with
MOLSCRIPT33 and Raster3D.34
The final model consists of residues 12–45 and 48–159
for one subunit (subunit 1) and residues 14–46 and 49–156
for the second (subunit 2). The N-terminal T7 tag is
largely disordered as are portions of the flexible binding
loop near residues 45–52. The electron density for the C
terminus is well defined for subunit 1, but it is poorer in
quality for subunit 2. Two glycerol molecules and a
sulfate ion located on a crystallographic 2-fold axis make
up the non-protein, non-solvent components of the
model. The structural model also contains 272 fully
occupied oxygen atoms for water molecules and five
half-occupied water molecules. The average B values for
the protein are a little high, but this correlates with the
weak density and presumed flexibility of the polypeptide
loops between the strands of the b-barrel.
The final R value for reflections with jFojO4s(jFoj) is
0.176 while the R for all reflections is 0.179. Table 2
contains refinement statistics for the structure.Protein Data Bank accession codes
Coordinates and structure factors have been deposited
in the Protein Data Bank with identifier 2BC3.Acknowledgements
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